About Penta
Who we are
Diversity and Inclusion
Our Network
Penta Foundation Italy
Penta ID Innovation
Annual reports
Our Activities
News & Events
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Call for services
Brighter Future Award
Archivio
Darunavir population pharmacokinetics in pregnancy
HIV-1 Drug Resistance and Second-line Treatment in Children Randomized to Switch at Low versus Higher RNA Thresholds
I was like, oh my God, what happens if it doesn’t work’? Young people living with HIV, clinical trial participation and the truth economy
Raltegravir in HIV-1 Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy
Ritonavir pharmacokinetics in pregnancy
Etravirine pharmacokinetics during pregnancy and postpartum
Maraviroc Pharmacokinetics in HIV-1-Infected Pregnant Women
I am scared of getting caught up in my lie’: challenges to self-reported adherence for young people living with HIV
Young people, clinical trials and ‘the HIV experience’: What can similarities across time and place tell us about growing up with HIV?
“But it’s my story”: exploring the experience and effect of telling children how they have acquired HIV
Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission
“But it’s my story”: exploring the experience and effect of telling children how they have acquired HIV
Young people, clinical trials and ‘the HIV experience’: What can similarities across time and place tell us about growing up with HIV?
‘I am scared of getting caught up in my lie’: challenges to self-reported adherence for young people living with HIV; accepted for presentation at AIDS Impact
The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update Decemebr 2014
Pediatric drug safety surveillance in FDA-AERS: a description of adverse events from GRIP project.
Treating hepatitis C virus in children: time for a new paradigm